Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro.
Koh YW, Shah MH, Agarwal K, McCarty SK, Koo BS, Brendel VJ, Wang C, Porter K, Jarjoura D, Saji M, Ringel MD.
Koh YW, et al. Among authors: saji m.
Endocr Relat Cancer. 2012 Jan 9;19(1):29-38. doi: 10.1530/ERC-11-0155. Print 2012 Feb.
Endocr Relat Cancer. 2012.
PMID: 22109971
Free PMC article.